Yara International ASA
DUS:IU2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Y
|
Yara International ASA
DUS:IU2
|
NO |
|
R
|
Rigel Pharmaceuticals Inc
F:RI2A
|
US |
|
B
|
Banco Santander SA
DUS:BSD2
|
ES |
|
B
|
Barclays PLC
F:BCY2
|
UK |
|
Galapagos NV
OTC:GLPGF
|
BE |
|
ActiveOps PLC
F:95D
|
UK |
Wall St Price Targets
IU2 Price Targets Summary
Yara International ASA
According to Wall Street analysts, the average 1-year price target for IU2 is 32.01 EUR with a low forecast of 20.08 EUR and a high forecast of 39.15 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is IU2's stock price target?
Price Target
32.01
EUR
According to Wall Street analysts, the average 1-year price target for IU2 is 32.01 EUR with a low forecast of 20.08 EUR and a high forecast of 39.15 EUR.
What is the Revenue forecast for Yara International ASA?
Projected CAGR
0%
Over the last 13 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 7 years is 0%.
What is the Operating Income forecast for Yara International ASA?
Projected CAGR
-4%
Over the last 13 years, the compound annual growth rate for Operating Income has been -1%. The projected CAGR for the next 7 years is -4%.
What is the Net Income forecast for Yara International ASA?
Projected CAGR
-9%
Over the last 13 years, the compound annual growth rate for Net Income has been -2%. The projected CAGR for the next 4 years is -9%.
